Bone Mets Flashcards

1
Q

What are the most common malignant bone lesions?

A

Metastatic bone tumors are the most common malignant bone lesions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common form of malignant bone mets tumor?

A

Prostate cancer is the most common form of malignant bone tumor.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What percentage of patients with advanced prostate cancer have bone metastases?

A

Up to 75% of patients with advanced diagnosis of prostate cancer have bone metastases.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which cancers commonly lead to metastatic bone disease?

A

Prostate, breast, and lung.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Is metastatic bone disease curable?

A

Metastatic bone disease is not curable; therefore, maintaining a certain quality of life for patients becomes important.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the treatment for painful metastatic bone tumors?

A

Palliative radiation therapy is used for painful metastatic bone tumors, typically at a dose of 30 Gy in 2-4 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Where are metastatic bone tumors most commonly located?

A

The most common location of metastatic bone tumors is in the thoracic spine.

They are also commonly seen in the hips, femur, and ribs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What factors influence the prognosis for metastatic bone disease?

A

The prognosis depends on the primary site, histology, and degree of metastases at the time of diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the average survival for lung cancer patients with bone metastases?

A

Lung cancer patients with bone metastases live an average of 6 to 7 months after diagnosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the median survival for breast cancer patients with bony involvement?

A

Breast cancer patients with bony involvement have a median survival of 19 to 25 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the average survival for prostate cancer patients with metastatic bone disease?

A

Prostate cancer patients with metastatic bone disease live an average of 12 to 53 months.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the clinical presentations of bone metastases?

A

Bone metastases cause pain and skeletal-related events (SREs), including pathologic fractures, spinal cord compression, and forced immobility. All of these are associated with a significant decrease in the quality of life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the treatment goal for bone metastases?

A

The treatment goal of bone metastases is prevention and reduction of the occurrence of skeletal-related events (SREs).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the goals of treatment for bone Mets?

A

Palliation of pain and prevention of fractures to weight-bearing bones are very important.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are common characteristics of bone metastases in middle-aged or elderly patients?

A

Painful osteolytic bone lesions that eat away at bone, swelling, anemia, weakness, pathological fractures, compression fractures of vertebrae, spinal cord compression, infections, and bleeding due to hyperglobulinemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the treatment of choice for bone metastases?

A

Radiation therapy is the treatment of choice.

17
Q

What therapies can be used for palliation of metastatic bone disease?

A

EBRT and radiopharmaceutical agents can be used for the palliation of metastatic bone disease.

18
Q

Which radiopharmaceutical agents provide pain relief for metastatic prostate carcinoma?

A

Strontium-89, Rhenium-186, and Samarium-153 have been shown to provide pain relief for patients with metastatic prostate carcinoma.

19
Q

What is the half-life of Strontium-89?

A

Strontium-89 has a half-life of 50.5 days.

20
Q

How is radionuclide therapy generally administered?

A

Radionuclide therapy is generally administered via IV on an outpatient basis with minimal side effects.

21
Q

What is the effectiveness of radiation therapy in treating bone metastases?

A

Radiation therapy is effective in local control of the lesion, with relief of pain and prevention of the loss of function of the bone.

22
Q

What percentage of patients with bone metastases experience significant pain relief after radiation therapy?

A

Over 50% of patients with bone metastases have significant pain relief after 5 to 10 fractions.

23
Q

What should spine treatment fields include for bone Mets treatments?

A

The fields should include the symptomatic vertebrae, with a one-vertebral-body margin above and below.

24
Q

How can healthy bone be shielded during radiation therapy?

A

MLCs can be used to shield healthy bone and reduce the amount of small bowel in the field.

25
Q

What is the standard dose for palliation in bone metastases?

A

The standard dose is 30 Gy in 10 fractions.

26
Q

Can optimal pain control be achieved with lower total doses?

A

Yes, optimal pain control is achievable with lower total doses and higher dose per fraction.

27
Q

What is an example of a lower total dose for pain control?

A

2000 cGy in 5 fractions.

Clinical trials have shown no significant difference in pain control between the standard dose and other fractionation schemes.

28
Q

What is a common single fraction dose for pain relief?

A

800 cGy in a single fraction.

This method provides adequate pain relief and saves the patient multiple trips to the clinic.